We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ekf Diagnostics Holdings Plc | LSE:EKF | London | Ordinary Share | GB0031509804 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 0.18% | 27.80 | 27.90 | 28.90 | 27.80 | 27.80 | 27.80 | 183,724 | 16:35:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Med, Dental, Hosp Eq-whsl | 52.61M | 2.35M | 0.0052 | 53.46 | 126.47M |
From Apr 2019 to Apr 2024
TIDMEKF
RNS Number : 9901Z
EKF Diagnostics Holdings PLC
21 December 2017
21 December 2017
EKF Diagnostics Holdings plc
("EKF Diagnostics" or the "Company")
Confirmation of share cancellation
Total voting rights
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed medical diagnostics business, refers to its announcement dated 3 October 2017 (the "Previous Announcement") and confirms that with effect from 22 December 2017 it will cancel 78,113 of the 205,561 Compensation Shares (as defined in the Previous Announcement (the "Cancellation"). EKF also confirms that the remaining 127,448 ordinary shares have been sold by one of the Majority Shareholders (as defined in the Previous Announcement) and the net proceeds of sale have been received by the Company.
Following the Cancellation, the Company's total issued share capital will consist of 457,554,636 ordinary shares of 1 pence each ("Ordinary Shares") with one voting right per share. The Company will not hold any Ordinary Shares in treasury.
Therefore, the total number of voting rights in the Company will be 457,554,636.
The above figure of 457,554,636 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
For further information please contact:
EKF Diagnostics Holdings plc www.ekfdiagnostics.com Christopher Mills, Non-Executive Tel: 029 2071 0570 Chairman Julian Baines, CEO Richard Evans, FD & COO N+1 Singer (Nomad & Broker) Tel: 020 7496 3000 Alex Price / Shaun Dobson Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCPGGUAPUPMGQU
(END) Dow Jones Newswires
December 21, 2017 02:00 ET (07:00 GMT)
1 Year Ekf Diagnostics Chart |
1 Month Ekf Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
